Cardiome Announces Agreement with Basilea for Distribution of Zevtera(R)/Mabelio(R) (Ceftobiprole) in Europe and Israel

VANCOUVER, Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has entered into a distribution and license agreement with Basilea for its antibiotic Zevtera®/Mabelio®. ... Biopharmaceuticals, Licensing, Distribution Cardiome Pharma, Basilea, Zevtera, Mabelio, Ceftobiprole
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news